Tag Archives: stocks

The Stock Market, From A Variety Of Viewpoints: Financial Advisors’ Daily Digest

SA Dividends, Income & Retirement Editor Robyn Conti here, subbing in for Gil, who’s observing Passover this week. I’ll do my best to fill his very talented and knowledgeable shoes and continue to keep you up to date daily on the latest FA analysis and news here on Seeking Alpha. Today’s FA Digest deals with different ways of looking at the stock market, but before we jump in, I wanted to thank you for accompanying me this week. It’s been my pleasure to bring you a variety of topics of interest to financial advisors, and I hope you enjoyed this week’s posts. Gil will be back in the captain’s chair next week. And now, on to today’s stories… In The Stock Market Is Not A Slot Machine, Nor A Vending Machine , Peter F. Way, CFA , presents a multi-faceted view of the markets from a behavioral finance and market makers’ perspective. He writes: Constant change keeps the market churning. Change in technology, change in competition, change in consumer attitudes, desires, change in opportunities, change in risk exposures, threats. What doesn’t change? Human nature, behavior. Financial markets anticipate, as well as react. To deal with both conditions participants must make forecasts. Good forecasts need GOOD information. GOOD information is not to be found in MIS-information – the deluge of largely irrelevant minutia flooding the print and electronic media that tells you what you already know (or think you know) – and “interesting” tidbits that distract, but are not relevant to what you need to know. BAD information – DIS-information – is intentionally misleading falsehoods, usually cleverly disguised and presented at times and in ways to get you to do what will help others while hurting you. Value transferred, not created. Peter then goes on to dissect how the market maker community assists big money managers in making timely trades, and provides an example of how their practices work by discussing how they view Constellation Brands (NYSE: STZ ). The bottom line: Advisors and investors need to pay attention to a variety of factors, from the potential for price changes to analyzing alternative options to when investments are made. Not rocket science, to be sure, but definitely an interesting and compelling point of view from someone with intimate knowledge of how market makers help engineer trades and move markets, and how they impact individual investors as a result. Charles Schwab offers a different perspective, offering a look at exit strategies from a technical and charting angle. In Pulling The Trigger: 3 Exit Strategy Philosophies , they prescribe three different types of exits: 1. Find support and resistance zones, 2. Let your profits run, and 3. Take profits (but not necessarily all of them). It’s a bit of a departure from the typical fundamental focus of most SA authors, but no less valuable and useful for advisors and investors who like to incorporate technical analysis and charting into their strategies. Providing more of a 30,000-foot-view of the markets, William Koldus, CFA, CAIA , hypothesizes that, like all good things, the bull market we’ve enjoyed for so many years may, indeed, be coming to an end. He cites underwhelming Q1 earnings, emerging inflation, and soaring share prices returning to reality as reasons the bull market may be winding down. His thesis? “Investors should turn their focus to late stage cyclical plays, as the bulk of the gains for the broader equity market have been achieved in the current bull market.” And from the world of retirement planning and money management, George Schneider discusses self-sabotaging behaviors that often plague investors as they find ways to procrastinate saving for retirement, and suggests a variety of common-sense solutions for turning the ship around, such as prolonging one’s working years, saving early and often, and leveraging employer-sponsored retirement plans and other savings vehicles like traditional IRAs. Of course, the underlying message is that advisors have an opportunity to help clients right their retirement ships by making smart, informed decisions about their money and portfolios, making for smooth sailing into their happy golden years. And finally, we continue to keep watchful eye on the economy here at Seeking Alpha. As such, here’s some of the latest news and views: Tim Duy warns the Fed may shed its dovish feathers and reveal a more hawkish approach going forward . James Picerno writes that next week’s April jobs report will impact whether markets remain bullish or take a bearish turn. Eric Parnell takes a look at the good signs, and the not-so-good ones, for the U.S. economy going forward. Comstock dissects past Fed moves, and speculates on how future Fed decisions may impact stocks.

Skyworks Guidance Lags By $50 Mil On Petering Apple iPhone Demand

Apple ’s ( AAPL ) “iPhone drag” tugged Skyworks Solutions ’ ( SWKS ) fiscal Q3 guidance by $50 million late Thursday, prompting shares of radio-frequency chip rivals Broadcom ( AVGO ) and Qorvo ( QRVO ) to topple early Friday. Skyworks stock led a broad Apple chip sphere fall, down 4.5%, near 68, in morning trading on the stock market today . Shares of competitors Broadcom and Qorvo were down a respective 2% and 2.5%. NXP Semiconductors ( NXPI ), Qualcomm ( QCOM ) and InvenSense ( INVN ) stocks followed, down 1%, 3% and 4%, respectively. Apple stock was down 2%. For its fiscal Q2, which ended April 1, Skyworks reported $775.1 million in sales and $1.25 earnings per share minus items, in line and topping the consensus of 25 analysts polled by Thomson Reuters for $775.6 million and $1.24. But EPS slipped to single-digit growth for the first time in 13 quarters, rising 9% year over year. Sales rose 2%, in the single-digit range for the first time in 14 quarters. Both metrics have decelerated for five consecutive quarters. Current-quarter guidance for $750 million in sales and $1.21 EPS ex items would be down 7% and 10%, respectively, vs. the year-earlier quarter. On a year-over-year basis, sales have never declined in the past five years. EPS has declined twice, but this quarter’s decline would be the biggest. And both metrics lagged the consensus for $800.5 million and $1.32. Mizuho analyst Vijay Rakesh blamed the “iPhone drag” for Skyworks’ weak guidance. On Tuesday, Apple reported its first year-over-year decline in iPhone sales and its first quarterly revenue drop in 13 years. Apple CEO Tim Cook said Tuesday that the company planned to cut channel inventories in the June quarter “in light of the macroeconomic environment.” Late Tuesday, supplier Cirrus Logic ( CRUS ) offered Q3 guidance that also missed Wall Street views. But Skyworks expects a strong September quarter, with 20% and 40% content gains at Samsung and Huawei. On average, Chinese smartphones are growing content by 20% year over year, Rakesh wrote in a research report. Rakesh cut his price target on Skyworks stock to 99 from 105 but reiterated a buy rating. Cowen analyst Timothy Arcuri estimates that 40 million to 50 million iPhones will be sold in the June quarter, leading to better upside in Skyworks’ fiscal Q4. But he adds that Qorvo might be a stronger RF competitor now. Both analysts suggest that Skyworks look to diversify amid the slowing Chinese and iPhone markets. Arcuri reduced his price target on Skyworks stock to 76 from 78 and kept his market perform rating.

Medivation Rejects Sanofi’s Buyout Bid; Sanofi ‘Remains Committed’

Biopharma firm Medivation ( MDVN ) rejected a $9.3 billion buyout proposal from big French pharma Sanofi ( SNY ) Friday morning, saying the offer undervalues the company. Medivation’s board unanimously voted against Sanofi’s bid of $52.50 a share in cash, which Sanofi first made by private letter on April 15 but made public on Thursday when it failed to get a response. Although that was around where Medivation was trading at the time, Sanofi said the stock has been pushed up lately by buyout rumors (including a report that AstraZeneca ( AZN ) is also interested), and that its offer is 50% higher than Medivation stock’s average price over the two months before the rumors surfaced. Medivation founder and CEO David Hung, however, claimed the price was unreasonably low due to the broad sell-off in drug stocks over the last eight months. “Sanofi’s opportunistically-timed proposal, which comes during a period of significant market dislocation, and prior to several important near-term events for the company, is designed to seize for Sanofi value that rightly belongs to our stockholders,” Hung said in a statement. Medivation stock bottomed at 26.41 on Feb. 9, a 63% drop from its then-52-week high set the previous March. In early trading on the stock market today , Medivation stock was down a fraction, near 56. Sanofi issued a brief response Friday promising to press on. “While to date Medivation has chosen not to enter into discussions regarding this value-creating transaction, Sanofi remains committed to the combination and looks forward to engaging directly with Medivation shareholders with regard to our proposal,” it said. Sanofi stock was down 4% in early trading Friday, near 41.